Publications

Cardiology

🔗 More Than Meets the Eye: Infective Endocarditis Presenting as Endogenous Endophthalmitis.Villasmil, R. J., Lattanzio, N., Burns, K., & Alkayali, T. (2021). More than meets the eye: Infective endocarditis presenting as endogenous endophthalmitis. Cureus, 13(4), e14745. https://doi.org/10.7759/cureus.14745
🔗 Not Your Usual Case of Culture-Negative Endocarditis: A Case Report of Bartonella Endocarditis.Villasmil, R. J., Sia, J., Motie, I., Rodriguez, L., & Kraitman, N. (2022). Not Your Usual Case of Culture-Negative Endocarditis: A Case Report of Bartonella Endocarditis. Cureus, 14(5), e24947. https://doi.org/10.7759/cureus.24947
🔗 Using Objective Electrocardiographic Data to Better Predict Mortality in Patients Hospitalized with COVID-19.Malik, B., Burns, K., Villasmil, R., Walo, R., Baez-Rodriguez, K., Wiese-Rometsch, W., & Whiteside, Z. (2023). Using Objective Electrocardiographic Data To Better Predict Mortality In Patients Hospitalized With COVID-19. Journal of Cardiac Failure, 29(4), 643–644. https://doi.org/10.1016/j.cardfail.2022.10.238
🔗 Heart failure ejection fraction class conversions: impact of biomarkers, co-morbidities, and pharmacotherapyLorenzo, C. J., Conte, J. I., Villasmil, R. J., Abdelal, Q. K., Pierce, D., Wiese-Rometsch, W., & Garcia-Fernandez, J. A. (2022). Heart failure ejection fraction class conversions: impact of biomarkers, co-morbidities, and pharmacotherapy. ESC heart failure, 9(4), 2538–2547. https://doi.org/10.1002/ehf2.13965
🔗 The Longer You Wait, the Harder It Gets: A Case for Adoption of Strain Imaging in Cardio-OncologyGardner, A., & Taylor, A. (2022, June). The Longer You Wait, the Harder It Gets: A Case for Adoption of Strain Imaging in Cardio-Oncology. 11(6), 8–11.

Critical Care & Emergency Medicine

🔗 Effect of a pharmacist-based toxicology consult service on appropriate use of intravenous N-acetylcysteine for acetaminophen toxicity: A retrospective cohort studySummerlin, J. A., Wang, K. M., McMahon, A. J., & Lund, J. A. (2023). Effect of a pharmacist-based toxicology consult service on appropriate use of intravenous N-acetylcysteine for acetaminophen toxicity: A retrospective cohort study. International journal of critical illness and injury science, 13(2), 54–59. https://doi.org/10.4103/ijciis.ijciis_88_22
🔗 V asopressin I nitiation as a S econd-Line Vaso P ressor in Early S eptic S hock (VISPSS)Ragoonanan, D., Nickelsen, P., Tran, N., Allen, B., Emborski, R., Legare, A., Villela, A., Hampson, L., Busey, K., Shomo, E., Broomfield, A., & Hailu, K. (2023). Vasopressin Initiation as a Second-Line VasoPressor in Early Septic Shock (VISPSS). Journal of intensive care medicine, 8850666231201364. Advance online publication. https://doi.org/10.1177/08850666231201364
🔗 Adverse events of undiluted intravenous push levetiracetam - A prospective observational studySummerlin, J. A., Scaturo, N., Lund, J. A., Wang, K. M., & Frank, M. A. (2023). Adverse events of undiluted intravenous push levetiracetam - A prospective observational study. The American journal of emergency medicine, 73, 182–186. Advance online publication. https://doi.org/10.1016/j.ajem.2023.08.046
🔗 Validation of the Critical-Care Pain Observation Tool in the emergency departmentCason, TH, Vilella, AL, Samai, K, Bonamer, J, King, TS & Lund, J. (2023, in review). Validation of the Critical-Care Pain Observation Tool in the emergency department: A prospective study. Submitted to Annals of Emergency Medicine.

Gastrointestinal

🔗 “Colitis Cystica Profunda: A Great Pretender”Ward, M., Burns, K., Nora, I., Wiese-Rometsch, W., & Loewe, C. J. (2021). S1869 Colitis Cystica Profunda: A Great Pretender. Official Journal of the American College of Gastroenterology | ACG, 116. https://journals.lww.com/ajg/fulltext/2021/10001/s1869_colitis_cystica_profunda__a_great_pretender.1873.aspx
🔗 An Educational Quality Improvement Initiative to Address Use of gFOBT, FIT and FIT-DNA by Healthcare ProfessionalsBusari, K., Bernstein, M., & Williams, R. (2021). S324 An Educational Quality Improvement Initiative to Address Use of gFOBT, FIT and FIT-DNA by Healthcare Professionals. Official Journal of the American College of Gastroenterology | ACG, 116. https://journals.lww.com/ajg/fulltext/2021/10001/s324_an_educational_quality_improvement_initiative.324.aspx
🔗 Langerhans Cell Histiocytosis Mimicking Inflammatory Bowel Disease: A Rare Presentation of Multiorgan Myeloid Neoplasm in a Geriatric PatientWard, M., Idogun, P., Seepaulsing, N., Brown, R., Domenico, C., & Corbett, S. (2021). S1868 Langerhans Cell Histiocytosis Mimicking Inflammatory Bowel Disease: A Rare Presentation of Multiorgan Myeloid Neoplasm in a Geriatric Patient. Official Journal of the American College of Gastroenterology | ACG, 116. https://journals.lww.com/ajg/fulltext/2021/10001/s1868_langerhans_cell_histiocytosis_mimicking.1872.aspx
🔗 Anastomotic Leaks Post Esophagectomy: Do Comorbidities Matter?Ward, M., Burns, K., Nora, I., Huston, J., Shridhar, R., & Meredith, K. (2021). S447 Anastomotic Leaks Post Esophagectomy: Do Comorbidities Matter? Official Journal of the American College of Gastroenterology | ACG, 116. https://journals.lww.com/ajg/fulltext/2021/10001/s447_anastomotic_leaks_post_esophagectomy__do.447.aspx
🔗 A Fractured Colon: An Unusual Macroscopic Finding in Microscopic ColitisWard, M., Kirkland, Z., Burns, K., & Murchie, B. (2021). S1870 A Fractured Colon: An Unusual Macroscopic Finding in Microscopic Colitis. Official Journal of the American College of Gastroenterology | ACG, 116. https://journals.lww.com/ajg/fulltext/2021/10001/s1870_a_fractured_colon__an_unusual_macroscopic.1874.aspx
🔗 Sars-cov-2 infection evoked hypoalbuminemia predicts progression to critical illness in patients with mild to severe liver diseaseNora, I., Ward, M. C., Sharma, M., Kayali, Z., Smith, R. A., & Wiese-Rometsch, W. (2022). Sa1428: SARS-COV-2 INFECTION EVOKED HYPOALBUMINEMIA PREDICTS PROGRESSION TO CRITICAL ILLNESS IN PATIENTS WITH MILD TO SEVERE LIVER DISEASE. Gastroenterology, 162(7), S-383. https://doi.org/10.1016/S0016-5085(22)60913-2
🔗 "Long Term Follow-up After Radiofrequency Ablation (RFA) of Barrett's Esophagus in a Relatively Low Risk Cohort."Corbett S, Nora I: "Long Term Follow-up After Radiofrequency Ablation (RFA) of Barrett's Esophagus in a Relatively Low Risk Cohort." Gastrointestinal Endoscopy 95.6 (2022): AB369.
🔗 Prognostic significance of CA 19-9Meredith, K., Huston, J., & Shridhar, R. (2021). Prognostic significance of CA 19-9. HPB, 23, S322. https://doi.org/10.1016/j.hpb.2020.11.819
🔗 Comparative outcomes of transthoracic versus transhiatal esophagectomyTakahashi, C., Shridhar, R., Huston, J., Blinn, P., Maramara, T., & Meredith, K. (2021). Comparative outcomes of transthoracic versus transhiatal esophagectomy. Surgery, 170(1), 263–270. https://doi.org/10.1016/j.surg.2021.02.036
🔗 High-volume surgeons have improved outcomes after robotic transthoracic esophagectomy in the community setting.Glasser, J., Schuster, C., Meredith, K., & Huston, J. (2021). High-Volume Surgeons Have Improved Outcomes after Robotic Transthoracic Esophagectomy in the Community Setting. Journal of the American College of Surgeons, 233(5). https://journals.lww.com/journalacs/fulltext/2021/11001/high_volume_surgeons_have_improved_outcomes_after.457.aspx
🔗 Age increases the likelihood of withdrawal of care after robotic esophagectomySchuster, C., Glasser, J., Meredith, K. L., & Huston, J. (2021). Age Increases the Likelihood of Withdrawal of Care after Robotic Esophagectomy. Journal of the American College of Surgeons, 233(5). https://journals.lww.com/journalacs/fulltext/2021/11002/age_increases_the_likelihood_of_withdrawal_of_care.439.aspx
🔗 Conduit perfusion time and anastomotic leaks after esophagectomy.Pipkin, C. T., Huston, J., & Meredith, K. L. (2021). Conduit Perfusion Time and Anastomotic Leaks after Esophagectomy. Journal of the American College of Surgeons, 233(5). https://journals.lww.com/journalacs/fulltext/2021/11001/conduit_perfusion_time_and_anastomotic_leaks_after.480.aspx
🔗 Anastomotic leaks post esophagectomy: Do comorbidities matter?Ward, M., Burns, K., Nora, I., Huston, J., Shridhar, R., & Meredith, K. (2021). S447 Anastomotic Leaks Post Esophagectomy: Do Comorbidities Matter? Official Journal of the American College of Gastroenterology | ACG, 116. https://journals.lww.com/ajg/fulltext/2021/10001/s447_anastomotic_leaks_post_esophagectomy__do.447.aspx
🔗 Robotic eTEP versus IPOM evaluation: the REVEAL multicenter randomized clinical trialPetro, C. C., Montelione, K. C., Zolin, S. J., Renton, D. B., Yunis, J. P., Meara, M. P., Costanzo, A., Diaz, K., McKenzie, K., Wilber, M., Fonseca, T., Tu, C., Olson, M. A., Krpata, D. M., Beffa, L. R., Poulose, B. K., Rosen, M. J., & Prabhu, A. S. (2023). Robotic eTEP versus IPOM evaluation: the REVEAL multicenter randomized clinical trial. Surgical endoscopy, 37(3), 2143–2153. https://doi.org/10.1007/s00464-022-09722-9
🔗 The Use of Indocyanine Green (ICYG) Angiography Intraoperatively to Evaluate Gastric Conduit Perfusion During Esophagectomy: Does It Impact Surgical Decision Making? (S024)2023 Scientific Session of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), Montréal, Canada, 19 March–April 1 2023: Podium Abstracts. (2023). Surgical Endoscopy, 37(2), 205–344. https://doi.org/10.1007/s00464-023-10071-4
🔗 Endoscopic trans-gastric stent placement for the management of post-operative pancreatic leakK. Meredith, G. LeBlanc, P. Blinn, J. Huston, R. Shridhar and S. Kucera Endoscopic trans-gastric stent placement for the management of post-operative pancreatic leak—ClinicalKey. (n.d.). Retrieved September 13, 2023

Infectious Disease

🔗 Covid-19 patients expressed distinct clinical trait signatures at index hospitalization across the four SARS-COV-2 pandemic waves in Florida.Sia, J. E., Idogun, P., Patel, D., Motie, I., Hamad, K., Geary, M., Seaman, J., & Wiese-Rometsch, W. (2022). COVID-19 Patients Expressed Distinct Clinical Trait Signatures at Index Hospitalization Across the Four SARS-CoV-2 Pandemic Waves in Florida. In C14. BURNOUT, DISPARITIES, AND OUTCOMES OF THE COVID-19 PANDEMIC (1–261, pp. A3698–A3698). American Thoracic Society. https://doi.org/10.1164/ajrccm-conference.2022.205.1_MeetingAbstracts.A3698
🔗 Longitudinal Characterization of Presentation Clinical Traits in Patients During Index and at Least One Readmission Post-Acute COVID-19Sia, J. E. D.; Idogun, P.; Patel, D.; Hamad, K.; Wiese-Rometsch, W..Abstracts from the 2022 Annual Meeting of the Society of General Internal Medicine. (2022). Journal of General Internal Medicine, 37(S2), 129–664. https://doi.org/10.1007/s11606-022-07653-8
🔗 Progression Risk Assessment in Hospitalized COVID-19 Patients with Extant Heart Failure: Multiple Chronic Conditions Matter Burns K, Patel D, Whiteside Z, Malik B, Thompson R, Villasmil R, Hamad KM, Wiese- Rometsch W: “Progression Risk Assessment in Hospitalized COVID-19 Patients with Extant Heart Failure: Multiple Chronic Conditions Matter”. American Journal of Respiratory and Critical Care Medicine, Volume 205, May 2022. 1.
🔗 COVID-19 Patients Expressed Distinct Clinical Trait Signatures at Index Hospitalization Across the Four SARS-CoV-2 Pandemic Waves in Florida.Sia, J. E., Idogun, P., Patel, D., Motie, I., Hamad, K., Geary, M., Seaman, J., & Wiese-Rometsch, W. (2022). COVID-19 Patients Expressed Distinct Clinical Trait Signatures at Index Hospitalization Across the Four SARS-CoV-2 Pandemic Waves in Florida. In C14. BURNOUT, DISPARITIES, AND OUTCOMES OF THE COVID-19 PANDEMIC (1–261, pp. A3698–A3698). American Thoracic Society. https://doi.org/10.1164/ajrccm-conference.2022.205.1_MeetingAbstracts.A3698
🔗 Comparing Outcomes in COVID-19 Patients Who Received Standard, Intermediate, or Treatment Dose Enoxaparin and Underwent Intensive CareAbstracts from the 2022 Annual Meeting of the Society of General Internal Medicine. (2022). Journal of General Internal Medicine, 37(S2), 129–664. https://doi.org/10.1007/s11606-022-07653-8
🔗 Corticosteroid treatment response in hospital/zed covid-19 patientsWilliams, Stephanie1; Lattanzio, Natalia1; Walo, Richard1; Hamad, Karen2; Wiese-Rometsch, Wilhelmine1; Seaman, Joseph1. 207: CORTICOSTEROID TREATMENT RESPONSE IN HOSPITALIZED COVID-19 PATIENTS. Critical Care Medicine 50(1):p 87, January 2022. | DOI: 10.1097/01.ccm.0000807152.48556.8a
🔗 Prediction of Progression to Critical Illness in Heart Failure Patients Hospitalized with COVID-19: Multiple Chronic Conditions MatterK. Burns, R. Walo, D. Patel, Z. Whiteside, B. Malik, R. Thompson, K. Baez Rodriguez, R. Villasmil, Q. Abdelal, K. Hamad, R. Heibel, W. Wiese-Rometsch Prediction of Progression to Critical Illness in Heart Failure Patients Hospitalized with COVID19: Multiple Chronic Conditions Matter Am J Respir Crit Care Med 2022;205:A4294
🔗 Newly Diagnosed Idiopathic Thrombocytopenia Post COVID-19 Vaccine AdministrationIdogun, P. O., Ward, M. C., Teklie, Y., Wiese-Rometsch, W., & Baker, J. (2021). Newly Diagnosed Idiopathic Thrombocytopenia Post COVID-19 Vaccine Administration. Cureus, 13(5), e14853. https://doi.org/10.7759/cureus.14853
🔗 Effectiveness of COVID- 19 Convalescent Plasma Infusion Within 48 Hours of Hospitalization with SARS CoV-2 InfectionLattanzio, N., Acosta-Diaz, C., Villasmil, R. J., Kirkland, Z., Bass, C., Yenari, S., Conte, J., Dawkins, K., Fonseca, T., Grimes, C., Stewart, A., Geary, M. E., Vore, H., Hamad, K., Wiese-Rometsch, W., Fiorica, J., Gordillo, M., Mercado, R., & Voelker, K. (2021). Effectiveness of COVID-19 Convalescent Plasma Infusion Within 48 Hours of Hospitalization With SARS-CoV-2 Infection. Cureus, 13(7), e16746. https://doi.org/10.7759/cureus.16746
🔗 COVID-19 Patients Expressed Distinct Clinical Trait Signatures at Index Hospitalization Across the Four SARS-CoV-2 Pandemic Waves in Florida.Sia, J. E., Idogun, P., Patel, D., Motie, I., Hamad, K., Geary, M., Seaman, J., & Wiese-Rometsch, W. (2022). COVID-19 Patients Expressed Distinct Clinical Trait Signatures at Index Hospitalization Across the Four SARS-CoV-2 Pandemic Waves in Florida. In C14. BURNOUT, DISPARITIES, AND OUTCOMES OF THE COVID-19 PANDEMIC (1–261, pp. A3698–A3698). American Thoracic Society. https://doi.org/10.1164/ajrccm-conference.2022.205.1_MeetingAbstracts.A3698
🔗 Clinicopathophysiologic traits driving progression to critical illness in hospitalized COVID-19 patients with heart failureVillasmil R, Pierce, D, Abdelal Q, Burns Katherine, Whiteside Z, Malik B, Lorenzo C, Patel D, Wiese-Rometsch W. Clinicopathophysiologic traits driving progression to critical illness in hospitalized COVID-19 patients with heart failure. Sarasota Memorial Hospital New Knowledge & Innovation Conference; May 2022.
🔗 COVID- 19 Patients Expressed Distinct Clinical Trait Signatures at Index Hospitalization Across the Four SARS-CoV-2 Pandemic Waves in FloridaSia, J. E., Idogun, P., Patel, D., Motie, I., Hamad, K., Geary, M., Seaman, J., & Wiese-Rometsch, W. (2022). COVID-19 Patients Expressed Distinct Clinical Trait Signatures at Index Hospitalization Across the Four SARS-CoV-2 Pandemic Waves in Florida. In C14. BURNOUT, DISPARITIES, AND OUTCOMES OF THE COVID-19 PANDEMIC (1–261, pp. A3698–A3698). American Thoracic Society. https://doi.org/10.1164/ajrccm-conference.2022.205.1_MeetingAbstracts.A3698
🔗 Longitudinal clinical traits of Heart Failure Patients Readmitted Post-COVID-19 Index Hospitalization.Abstracts from the 2022 Annual Meeting of the Society of General Internal Medicine. J GEN INTERN MED 37 (Suppl 2), 129–664 (2022). https://doi.org/10.1007/s11606-022-07653-8
🔗 Personalized baseline wrist stratification in hospitalized adult patients with COVID-19: Patient-similarity-based data sciences sheds some light.LATTANZIO, N., ACOSTA, C., VILLASMIL, R., ALKAYALI, T., GEORGE, J., TEKLIE, Y., WILLIAMS, S., STEWART, A., GRIMES, C., GEARY, M., HAMAD, K., WIESE-ROMETSCH, W., GORDILLO, M., & SEAMAN, J. (2021). PERSONALIZED BASELINE RISK STRATIFICATION IN HOSPITALIZED ADULT PATIENTS WITH COVID-19: PATIENT-SIMILARITY-BASED DATA SCIENCE SHEDS SOME LIGHT. Chest, 160(4), A1078–A1079. https://doi.org/10.1016/j.chest.2021.07.998
🔗 To "Mask" or "Not-To-Mask" for COV/0-19 Protection?Teklie Y & Beidas S. (2021) To "Mask" or "Not-To-Mask" for COV/0-19 Protection? J Oral Health Dent, 4(3): 353- 355.
🔗 Complete Blood Count Parameters Outperform Putative Inflammatory Markers in Predicting COVID-19 MortalityPrecious Idogun, John Sia, Mindy Ward, Dillan Patel, Wilhelmine Wiese-Rometsch, Anjan J. Patel; Complete Blood Count Parameters Outperform Putative Inflammatory Markers in Predicting COVID-19 Mortality: A Multimodal Machine Learning Model. Blood 2021; 138 (Supplement 1): 2967. doi: https://doi.org/10.1182/blood-2021-151849

Neurology

🔗 Copper Deficiency Myeloneuropathy Following Roux-en-Y Gastric Bypass in a 72-Year-Old FemaleKirkland, Z., Villasmil, R. J., Alookaran, J., Ward, M. C., & Stone, D. (2022). Copper Deficiency Myeloneuropathy Following Roux-en-Y Gastric Bypass in a 72-Year-Old Female. Cureus, 14(5), e25109. https://doi.org/10.7759/cureus.25109
🔗 Caring for hospitalized adults with autism spectrum disorder. Mersinger, S, Donnelly, C, Stone, D, Brown, C & Bonamer, J. (2023, in press). Caring for hospitalized adults with autism spectrum disorder. American Nurse Today.

Oncology

🔗 Effects of a Mindfulness-Based Stress Reduction Program Compared to a Breast Cancer-Education Support or Usual Care for Chemotherapy-Induced Peripheral Neuropathy (W29)(Breast) Lengacher, C. A., Reich, R. R., Rodriguez, C. S., Meng, H., Tinsley, S., Tofthagen, C., Lucas, J., Fonseca, T., Borstein, E., Lin, K., Hueluer, G., Chauca, K., Wang, J., Acosta, M., Joshi, A., Allen, A. P., Baier, C. E., Nidamanur, S., Park, J. Y. High Resolution Symptom Assessment Among Breast Cancer Survivors (BCS) Enrolled in a Mindfulness-Based Stress Reduction for Breast Cancer MBSR(BC) Program. 20th Annual APOS Conference; poster presentation; March 15-17, 2023.
🔗 Evaluation of a Virtual Mindfulness‐Based Stress Reduction Program for Advanced Stage Breast Cancer Survivors (vMBSR(BC)) Adapted for Black and Hispanic BCS. (T37)(Breast) Lengacher, C. A., Reich, R. R., Rodriguez, C. S., Drobisz, J., Hagen, L., Meng, H., Tinsley, S., Chauca, K., Lucas, J., Fonseca, T., Acosta, M., Baier, C., Joshi, A., Nidamanur, S., Pomatto, M., Surdovel, A., Allen, A. P., Kelly, T., Akinola, B., Park, J.Y. Evaluation of a Virtual Breast Cancer Education Support Program for Advanced Stage Breast Cancer Survivors (vBCES(BC)) for Black and Hispanic Breast Cancer Survivors. Psycho-Oncology. 2023;32(S1):85 https://doi.org/10.1002/pon.6090 [
🔗 High Resolution Symptom Assessment Among Breast Cancer Survivors (BCS) Enrolled in a Mindfulness‐Based Stress Reduction for Breast Cancer MBSR(BC) Program (W28)(Breast) Lengacher, C. A., Reich, R. R., Rodriguez, C. S., Meng, H., Tinsley, S., Tofthagen, C., Lucas, J., Fonseca, T., Borstein, E., Lin, K., Hueluer, G., Chauca, K., Wang, J., Acosta, M., Joshi, A., Allen, A. P., Baier, C. E., Nidamanur, S., Park, J. Y. High Resolution Symptom Assessment Among Breast Cancer Survivors (BCS) Enrolled in a Mindfulness‐Based Stress Reduction for Breast Cancer MBSR(BC) Program. Psycho-Oncology. 2023;32(S1):60 https://doi.org/10.1002/pon.6090 [doi.org].
🔗 Evaluation of a Virtual Breast Cancer Education Support Program for Advanced Stage Breast Cancer Survivors for Black and Hispanic Breast Cancer Survivors. (T38)(Breast) Lengacher, C. A., Reich, R. R., Rodriguez, C. S., Drobisz, J., Hagen, L., Meng, H., Tinsley, S., Chauca, K., Lucas, J., Fonseca, T., Acosta, M., Baier, C. E., Joshi, A., Nidamanur, S., Pomatto, M., Surdovel, A., Allen, A. P., Kelly, T., Akinola, B. Park, J. Y. Evaluation of a Virtual Mindfulness‐Based Stress Reduction Program for Advanced Stage Breast Cancer Survivors (vMBSR(BC)) Adapted for Black and Hispanic BCS. Psycho-Oncology. 2023;32(S1):84-85 https://doi.org/10.1002/pon.6090 [doi
🔗 A phase I dose escalation and expansion study of the next generation oral SERD AZD9833 in women with ER-positive, HER2-negative advanced breast cancer.(Breast) Hamilton, E. P., Oliveira, M., Banerji, U., Hernando, C., Garcia-Corbacho, J., Armstrong, A., Ciruelos, E., Patel, M. R., Incorvati, J., Twelves, C., Brier, T., Carroll, D., Fox, S., Klinowska, T., Lindemann, J. P. O., Mather, R., Maudsley, R., McGuinness, S., Sykes, A., & Baird, R. (2020). A phase I dose escalation and expansion study of the next generation oral SERD AZD9833 in women with ER-positive, HER2-negative advanced breast cancer. Journal of Clinical Oncology, 38(15_suppl),
🔗 A phase 3 comparison of AZD9833 (camizestrant) plus palbociclib, versus anastrozole plus palbociclib, for patients with ER-positive, HER2-negative advanced breast cancer who have not previou(Breast) Im, S.-A., Hamilton, E. P., Llombart Cussac, A., Baird, R. D., Ettl, J., Goetz, M. P., Iwata, H., Joy, A. A., Neven, P., Haddad, V., Walding, A. S., Selvi Miralles, M., Bartlett, C. H., & Andre, F. (2021). SERENA-4: A phase 3 comparison of AZD9833 (camizestrant) plus palbociclib, versus anastrozole plus palbociclib, for patients with ER-positive, HER2-negative advanced breast cancer who have not previously received systemic treatment for advanced disease. Journal of Clinical Oncolog
🔗 The Longer You Wait, the Harder It Gets: A Case for Adoption of Strain Imaging in Cardio-Oncology Click to view full text Publication(Cardiology) Gardner, A., & Taylor, A. (2022, June). The Longer You Wait, the Harder It Gets: A Case for Adoption of Strain Imaging in Cardio-Oncology. 11(6), 8–11.
🔗 A Rare Case of a Patient with Hairy Cell Leukemia Developing Blastoid Marginal Zone B Cell Lymphoma.(Hematology) Teklie, Y., Bell, S., Idogun, P., & Venigalla, M. (2021). A Rare Case of a Patient With Hairy Cell Leukemia Developing Blastoid Marginal Zone B-Cell Lymphoma. Cureus, 13(7), e16239. https://doi.org/10.7759/cureus.16239
🔗 Hemorrhagic Chemosis Associated With lsatuximab Use in an Elderly Lady With Multiple Myeloma.(Hematology) Idogun, P. O., & Kayali, Z. (2022). Hemorrhagic Chemosis Associated With Isatuximab Use in an Elderly Lady With Multiple Myeloma. Cureus, 14(3), e22764. https://doi.org/10.7759/cureus.22764
🔗 "A Case Report of Plasmablastic Lymphoma with Unusual Presentation: How Do Socioeconomic Factors Contribute to Cancer Survival?"(Hematology) Idogun, P., Rebernigg, J., Teklie, Y., King, A., & Ke, N. (2022). A Case Report of Plasmablastic Lymphoma with Unusual Presentation: How Do Socioeconomic Factors Contribute to Cancer Survival? Frontiers in Medical Case Reports, 03(04). https://doi.org/10.47746/FMCR.2022.3402
🔗 Comparison of colorectal cancer location and metastasis site in patients aged 50-75 vs. Age 75 and older in community and academic practice.(Gastro-Intestinal) Busari, K. A., Williams, R., Huston, J., Gachette, D., Stewart, O., & Meredith, K. L. (2021). Comparison of colorectal cancer location and metastasis site in patients aged 50 to 75 versus age 75 and older in community and academic practice. Journal of Clinical Oncology, 39(15_suppl), e15595–e15595. https://doi.org/10.1200/JCO.2021.39.15_suppl.e15595
🔗 Evaluation of the current treatment strategies for pancreatic neuroendocrine tumors <1 cm.(Gastro-Intestinal) Meredith K, Huston J, Shridhar R. Evaluation of the current treatment strategies for pancreatic neuroendocrine tumors: a propensity score matched analysis. HPB. 2021;23 (Suppl 1): 291-2.
🔗 Incidence and outcomes of patients >75 years old diagnosed with metastatic colorectal cancer.(Gastro-Intestinal) Schuster C, Busari K, Glasser J, Shridhar R, Huston J, Meredith K. Incidence and outcomes of patients >75 years old diagnosed with metastatic colorectal cancer. Ann Surg Oncol. 2021;28 (Suppl. 1S): 80.
🔗 Demographic differences of colorectal cancer in the community and academic setting in patients over the age of 75 compared to those aged 50 to 75.(Gastro-Intestinal) Busari, K. A., Williams, R., Huston, J., Stewart, O., Gachette, D., & Meredith, K. L. (2021). Demographic differences of colorectal cancer in the community and academic setting in patients over the age of 75 compared to those aged 50 to 75. Journal of Clinical Oncology, 39(15_suppl), e15594–e15594. https://doi.org/10.1200/JCO.2021.39.15_suppl.e15594
🔗 Surgical outcomes and mortality in elderly patients diagnosed with colorectal cancer. Gastroenterology(Gastro-Intestinal) Gachette D, Williams R, Huston J, Busari K, Stewart O, Meredith K. Surgical outcomes and mortality in elderly patients diagnosed with colorectal cancer. Gastroenterology. 2021;160(6) S872-873.
🔗 Racial, sex, and socioeconomic differences between colorectal cancer patients ages 50-75 vs. 75+(Gastro-Intestinal) Stewart O, Williams R, Huston J, Busari K, Gachette D, Meredith K. Racial, sex, and socioeconomic differences between colorectal cancer patients ages 50-75 vs. 75+. Gastroenterology. 2021;160(6)S387–388.
🔗 Evaluation of the current treatment strategies for poorly differentiated neuroendocrine tumors. (Gastro-Intestinal) Meredith K, Huston J, Shridhar R. Evaluation of the current treatment strategies for pancreatic neuroendocrine tumors: a propensity score matched analysis. HPB. 2021;23 (Suppl 1): 291-2.
🔗 2021 NCC/CATS/CSTCVS/STM expert consensus on perioperative immunotherapy for esophageal cancer.(Gastro-Intestinal) Qiu, B., Cai, K., Chen, C., Chen, J., Chen, K. N., Chen, Q. X., Cheng, C., Dai, T. Y., Fan, J., Fan, Z., Hu, J., Hu, W. D., Huang, Y. C., Jiang, G. N., Jiang, J., Jiang, T., Jiao, W. J., Li, H. C., Li, Q., Liao, Y. D., … He, J. (2021). Expert consensus on perioperative immunotherapy for local advanced non-small cell lung cancer. Translational lung cancer research, 10(9), 3713–3736. https://doi.org/10.21037/tlcr-21-634
🔗 Evaluation of the current treatment strategies for pancreatic neuroendocrine tumors: a propensity score matched analysis.(Gastro-Intestinal) Meredith K, Huston J, Shridhar R. Evaluation of the current treatment strategies for pancreatic neuroendocrine tumors: a propensity score matched analysis. HPB. 2021;23 (Suppl 1): 291-2.
🔗 Toxicity and efficacy of stereotactic body radiation therapy vs. intensity-modulated radiation therapy for the treatment of locally advanced pancreatic cancer in a phase 3 trial.(Gastro-Intestinal) Goodman K, Pishvaian M, Lopez C, Meredith K, et al. Toxicity and efficacy of stereotactic body radiation therapy vs. intensity-modulated radiation therapy for the treatment of locally advanced pancreatic cancer in a phase 3 trial. J Clin Oncol. 2023; 41(suppl 4): 713. doi: 10.1200/JCO.2023.41.3_suppl.713
🔗 Intra-arterial gemcitabine vs IV gemcitabine PK substudy in patients with locally advanced pancreatic cancer.(Gastro-Intestinal) Zureikat A, Pishvaian M, Meredith K, et al. Intra-arterial gemcitabine vs. IV gemcitabine PK substudy in patients with locally advanced pancreatic cancer. J Clin Oncol. 2023; 41(suppl 4): 728. doi: 10.1200/JCO.2023.41.3_suppl.728
🔗 Targeted intra-arterial gemcitabine vs. continuation of IV gemcitabine plus nab-paclitaxel following induction with sequential IV gemcitabine plus nab-paclitaxel and radiotherapy.(Gastro-Intestinal) Pishvaian, M. J., Zureikat, A. H., Lopez, C. D., Meredith, K., Zervos, E. E., Hatoum, H., Chung, K. Y., Berg, D. J., Ucar, A., Gandhi, R. T., Nazemzadeh, R., Parikh, N., Novelli, P. M., Kouri, B., Laing, C., Boone, B. A., Johnson, T., Bates, S. E., Agah, R., & Goodman, K. A. (2023). Targeted intra-arterial gemcitabine vs. Continuation of IV gemcitabine plus nab-paclitaxel following induction with sequential IV gemcitabine plus nab-paclitaxel and radiotherapy for unresecta
🔗 Incidence and clinical characteristics of patients with LAPC and mesenteric vein thrombosis and current treatment paradigm.(Gastro-Intestinal) Zureikat, A. H., Pishvaian, M. J., Lopez, C. D., Meredith, K., Zervos, E. E., Hatoum, H., Chung, K. Y., Tsobanoudis, A., Berg, D. J., Ucar, A., Nazemzadeh, R., Bates, S. E., Goodman, K. A., Johnson, T., Parikh, N., Kouri, B., Laing, C., Boone, B. A., Qureshi, I., & Agah, R. (2023). Incidence and clinical characteristics of patients with LAPC and mesenteric vein thrombosis and current treatment paradigm. Journal of Clinical Oncology, 41(4_suppl), 714–714. https://doi.org/1
🔗 Outcomes of adjuvant radiation therapy after chemotherapy in resected extrahepatic cholangiocarcinoma: A National Cancer Database analysis(Gastro-Intestinal) Shridhar, R., Blinn, P., Huston, J., & Meredith, K. L. (2023). Outcomes of adjuvant radiation therapy after chemotherapy in resected extrahepatic cholangiocarcinoma: A National Cancer Database analysis. Cancer, 129(6), 890–900. https://doi.org/10.1002/cncr.34625
🔗 Prediction of risk factors associated with readmission after robotic esophagectomy.(Gastro-Intestinal) Meredith, K. L., LeBlanc, G., Takahashi, C., Huston, J., & Shridhar, R. (2023). Prediction of risk factors associated with readmission after robotic esophagectomy. Journal of Clinical Oncology, 41(4_suppl), 328–328. https://doi.org/10.1200/JCO.2023.41.4_suppl.328
🔗 A decade experience with robotic assisted trans-thoracic esophagectomy. - International Conference on Surgical Cancer Care (Page 236)(Gastro-Intestinal) LeBlanc G, Blinn P, Huston J, Shridhar R, Meredith K. A decade experience with robotic assisted trans-thoracic esophagectomy. Ann Surg Oncol. 2023; 30 (Suppl. 1): 236. doi: 10.1245/s10434-023-13332-7
🔗 RADIOFREQUENCY ABLATION OF RENAL TUMORS 3-7 CM WITH DIRECT REAL TIME TEMPERATURE MONITORING USING NON-CONDUCTING FIBEROPTIC THERMISTORS: TECHNIQUE AND 14-YEAR FOLLOW UP OF ONCOLOGIC AND REN(Gastro-Intestinal) Benjamin Behers,1 Spencer Kortum,1 Genesis Dolgetta,2 Tonya S. King,2 and Robert I. Carey1 1 Florida State University College of Medicine 1 Sarasota Memorial Hospital Research Institute2 RADIOFREQUENCY ABLATION OF RENAL TUMORS 3-7 CM WITH DIRECT REAL TIME TEMPERATURE MONITORING USING NONCONDUCTING FIBEROPTIC THERMISTORS: TECHNIQUE AND 14-YEAR FOLLOW UP OF ONCOLOGIC AND RENAL FUNCTION OUTCOMES
🔗 Comparative outcomes of laparoscopic and robotic approaches to gastrectomy: a National Cancer Database study(Gastro-Intestinal) Takahashi, C., Glasser, J., Schuster, C., Huston, J., Shridhar, R., & Meredith, K. (2023). Comparative outcomes of laparoscopic and robotic approaches to gastrectomy: a National Cancer Database study. Surgical endoscopy, 10.1007/s00464-023-10204-9. Advance online publication. https://doi.org/10.1007/s00464-023-10204-9
🔗 Comparison of prostate biopsy grade obtained by human pathologists versus an artificial intelligence algorithm for predicting biochemical recurrence after radical prostatectomy.(Urology) Calle Claire de la, Vidotto Thiago, Erak Eric, Salles Daniela, Dairo Oluwademilade, Pavlovich Christian, Han Misop, Cho Joonyoung, Suh In Hye, Chang Hye Yoon, Kim Sun Woo, Gorin Michael, & Lotan Tamara. (2023). PD27-11 COMPARISON OF PROSTATE BIOPSY GRADE OBTAINED BY HUMAN PATHOLOGISTS VERSUS AN ARTIFICIAL INTELLIGENCE ALGORITHM FOR PREDICTING BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY. Journal of Urology, 209(Supplement 4), e746. https://doi.org/10.1097/JU.0000000000003305.
🔗 Acute Bone Pain: An Analysis of Symptom Management Interventions After Administration of Granulocyte-Colony-Stimulating Factors for Myelosuppression(Symptom Management) Mclean E. (2020). Acute Bone Pain: An Analysis of Symptom Management Interventions After Administration of Granulocyte-Colony-Stimulating Factors for Myelosuppression. Clinical journal of oncology nursing, 24(2), 165–169. https://doi.org/10.1188/20.CJON.165-169
🔗 Evaluation of a novel sequential treatment protocol for acute immune thrombocytopenia at a large community health care system(Hematology) Abby Rose Broomfield, PharmD Candidate; Morgan LaMarc, PharmD Candidate; Sierra Parsons, PharmD Candidate Bren Magruder, PharmD; Justin Presutto , PharmD, MBA, BCOP Evaluation of a novel sequential treatment protocol for acute immune thrombocytopenia at a large community health care system
🔗 Evaluation of a novel sequential treatment protocol for acute immune thrombocytopenia at a large community health care system(Hematology) Broomfield, A.R.; LaMarc, M.T.; Parsons, S.R.; Magruder, B.D.; Presutto, J.T.* Evaluation of a novel sequential treatment protocol for acute immune thrombocytopenia at a large community health care system
🔗 A first-in-human phase I dose-escalation trial of the B7-H6/CD3 T-cell engager BI 765049 ± ezabenlimab (BI 754091) in patients with advanced solid tumors expressing B7-H6.Falchook, G. S., Patel, M. R., Ulahannan, S. V., Maier, D., Hipp, S., Azuma, H., & Spigel, D. R. (2022). A first-in-human phase I dose-escalation trial of the B7-H6/CD3 T-cell engager BI 765049 ± ezabenlimab (BI 754091) in patients with advanced solid tumors expressing B7-H6. Journal of Clinical Oncology, 40(16_suppl), TPS3175–TPS3175. https://doi.org/10.1200/JCO.2022.40.16_suppl.TPS3175
🔗 480 A first-in-human phase I dose-escalation trial of the B7-H6/CD3 T-cell engager BI 765049 ± ezabenlimab (BI 754091) in patients with advanced solid tumors expressing B7-H6Gerald Falchook, David Spigel, Manish Patel, Babar Bashir, Susanna Ulahannan, Christine Duffy, Daniela Maier, & Hisaya Azuma. (2021). 480 A first-in-human phase I dose-escalation trial of the B7-H6/CD3 T-cell engager BI 765049 ± ezabenlimab (BI 754091) in patients with advanced solid tumors expressing B7-H6. Journal for ImmunoTherapy of Cancer, 9(Suppl 2), A510. https://doi.org/10.1136/jitc-2021-SITC2021.480

Rehabilitation

🔗Promoting a culture of patient safety: Strict total feeds intervention for self-feeding patients with high riskKapinos, J, Sweeney, T, Hofmann, T, & Bonamer, J. (2023, in press). Promoting a culture of patient safety: Strict total feeds intervention for self-feeding patients with high risk. Submitted to Journal for Health Care Quality.

Workforce Development/Healthcare Environment

🔗 Self-Care Strategies for Professional Development Transcendental Meditation Reduces Compassion Fatigue and Improves Resilience for NursesBonamer, J. (Rheingans), & Aquino-Russell, C. (2019). Self-Care Strategies for Professional Development: Transcendental Meditation Reduces Compassion Fatigue and Improves Resilience for Nurses. Journal for Nurses in Professional Development, 35(2). https://journals.lww.com/jnsdonline/fulltext/2019/03000/self_care_strategies_for_professional_development_.6.aspx
🔗 Multi-site Research Playbook: A practical guide to support multi-site research studies for greater impact.Shirey, M.R., Bonamer, J., Clarke, C., Hass, S., Ivory, C., Kitto, S., Price, D., Weiss, M., Yakusheva, O., Chappell, K., Johantgen, M. (Ed). (2021). Multi-site Research Playbook: A practical guide to support multi-site research studies for greater impact. Silver Spring, MD: American Nurses Credentialing Center’s Research Council. American Nurses Credentialing Center.
🔗 Excellence in Nursing Preceptorship-to-Hire, part 1Letourneau, R., Robinson, L., Cruz, V., Pryor, S., Williams, K., & Bonamer, J. (2023). Excellence in Nursing Preceptorship-to-Hire, part 1. Nursing Management, 54(1). https://journals.lww.com/nursingmanagement/fulltext/2023/01000/excellence_in_nursing_preceptorship_to_hire,_part.3.aspx
🔗Measuring Council Health to Transform Shared Governance Processes and PracticeHess, R. G. J., Bonamer, J. I., Swihart, D., & Brull, S. (2020). Measuring Council Health to Transform Shared Governance Processes and Practice. JONA: The Journal of Nursing Administration, 50(2). https://journals.lww.com/jonajournal/fulltext/2020/02000/measuring_council_health_to_transform_shared.10.aspx
🔗 Transcendental Meditation® improves clinical nurse-well being: a mixed method randomized controlled trial. Bonamer, J, Kutash, M, Hartranft, S, Aquino-Russell, C, & Johnson, A. (2023, in review). Transcendental Meditation® improves clinical nurse-well being: a mixed method randomized controlled trial. Submitted to Journal of Nursing Administration.
🔗 Improving antimicrobial use through better diagnosis: The relationship between diagnostic stewardship and antimicrobial stewardshipKu, T. S. N., Al Mohajer, M., Newton, J. A., Wilson, M. H., Monsees, E., Hayden, M. K., Messacar, K., Kisgen, J. J., Diekema, D. J., Morgan, D. J., Sifri, C. D., & Vaughn, V. M. (2023). Improving antimicrobial use through better diagnosis: The relationship between diagnostic stewardship and antimicrobial stewardship. Infection control and hospital epidemiology, 1–8. Advance online publication. https://doi.org/10.1017/ice.2023.156

RSS